Celldex Therapeutics Cash from Financing Quarterly:
114.51M for March 31, 2013Celldex Therapeutics Historical Cash from Financing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 114.51M |
| Dec. 31, 2012 | 19.57M |
| Sept. 30, 2012 | 9.58M |
| June 30, 2012 | -1.309M |
| March 31, 2012 | 51.91M |
| Dec. 31, 2011 | 0.129M |
| Sept. 30, 2011 | -0.023M |
| June 30, 2011 | 35.88M |
| March 31, 2011 | -7.549M |
| Dec. 31, 2010 | 9.961M |
| Sept. 30, 2010 | 0.334M |
| June 30, 2010 | 0.381M |
| March 31, 2010 | 0.141M |
| Dec. 31, 2009 | -2.822M |
| Sept. 30, 2009 | -0.031M |
| June 30, 2009 | 0.429M |
| March 31, 2009 | -0.041M |
| Dec. 31, 2008 | 0.0338M |
| Sept. 30, 2008 | -0.089M |
| June 30, 2008 | 10.85M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Financing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More
CLDX Cash from Financing Quarterly Benchmarks
| Companies | |
|---|---|
| Ariad Pharmaceuticals | 309.63M |
| Array BioPharma | |
| Insmed | 10.13M |
CLDX Cash from Financing Quarterly Rankings
| Overall |
96th percentile 298 of 7593 |
| Sector |
96th percentile 22 of 650 in Healthcare |
| Industry |
96th percentile 9 of 237 in Biotechnology |
CLDX Cash from Financing Quarterly Range, Past 5 Years
| Minimum | -7.549M | Mar 2011 |
| Maximum | 114.51M | Mar 2013 |
| Average | 12.09M |
